PhAST

PhAST Corp.

5 Investors

Biotechnology Diagnostics

BOSTON, MA

PhAST Corp. is a biotechnology company specializing in the transformation of infectious disease diagnostics through innovative rapid diagnostic technology. With a focus on minimizing turnaround times for pathogen detection and testing, PhAST Corp. aims to enhance patient care by enabling timely treatment decisions.

Products & Team

Rapid Diagnostic Technology

Diagnostic TechnologySeed

PhAST Corp. is developing a rapid diagnostic technology that utilizes single-cell imaging to provide real-time, actionable data about microorganisms. This innovative approach focuses on closely analyzing individual cells to enhance the speed and accuracy of pathogen detection and antibiotic susceptibility testing.

Value Proposition

The technology solves the problem of prolonged diagnostic times in microbiology by quickly delivering critical information, thus aiding healthcare professionals in making prompt and informed treatment decisions.

Pain Points

Addressing the need for fast and accurate identification of pathogens and ensuring timely treatment decisions to combat antibiotic resistance.

Single-cell imaging for precise analysisReal-time diagnostic resultsEnhanced speed for faster clinical decision-makingSupports antibiotic susceptibility testing